Andrew Aronsohn to Hepatitis C, Chronic
This is a "connection" page, showing publications Andrew Aronsohn has written about Hepatitis C, Chronic.
Connection Strength
2.803
-
You Can't Have One Without the Other: Innovation and Ethical Dilemmas in Gastroenterology and Hepatology. Clin Gastroenterol Hepatol. 2021 10; 19(10):2015-2019.
Score: 0.671
-
Current Management of Chronic Hepatitis B and C in Chronic Kidney Disease. Adv Chronic Kidney Dis. 2015 Sep; 22(5):352-60.
Score: 0.484
-
Interferon-combination strategies for the treatment of chronic hepatitis C. Semin Liver Dis. 2014 Feb; 34(1):30-6.
Score: 0.441
-
Impact of age on viral kinetics of peginterferon alfa-2a/ribavirin in chronic hepatitis C: final analysis from the PROPHESYS cohort. J Viral Hepat. 2014 May; 21(5):377-80.
Score: 0.425
-
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020 02; 71(2):686-721.
Score: 0.329
-
Long-term outcomes after treatment with interferon and ribavirin in HCV patients. J Clin Gastroenterol. 2009 Aug; 43(7):661-71.
Score: 0.317
-
Timing Is Everything: Managing Hepatitis C Virus in Liver Transplant Candidates. Transplantation. 2017 05; 101(5):898-899.
Score: 0.136